Schedule 13G ownership disclosure
Odonate Therapeutics, Inc.
Security class unavailable · CUSIP: 676079106
Event date: 2021-03-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 101
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-21-000358
- Form type
- SC 13G
- Filer
- Odonate Therapeutics, Inc.
- CIK
- CIK 1717452
- Filed
- Apr 12, 2021
- Reporting period
- Mar 31, 2021
- Description
- Schedule 13G beneficial ownership